Inotiv Crecimiento futuro

Future controles de criterios 0/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Inotiv de 9.9% y 3.6% respectivamente, mientras que el BPA crecerá en un 11.2% al año.

Información clave

9.9%

Tasa de crecimiento de los beneficios

11.2%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Life Sciences	16.9%
Tasa de crecimiento de los ingresos	3.6%
Rentabilidad financiera futura	n/a
Cobertura de analistas	Low
Última actualización	08 Apr 2024

Actualizaciones recientes sobre el crecimiento futuro

Earnings Release: Here's Why Analysts Cut Their Inotiv, Inc. (NASDAQ:NOTV) Price Target To US$12.81

Dec 13

Recent updates

Inotiv, Inc.'s (NASDAQ:NOTV) 57% Dip In Price Shows Sentiment Is Matching Revenues

Apr 26

Inotiv (NASDAQ:NOTV) Takes On Some Risk With Its Use Of Debt

Mar 19

Inotiv, Inc.'s (NASDAQ:NOTV) Price Is Right But Growth Is Lacking After Shares Rocket 34%

Feb 13

Inotiv, Inc. (NASDAQ:NOTV) Stock Rockets 61% But Many Are Still Ignoring The Company

Dec 18

Earnings Release: Here's Why Analysts Cut Their Inotiv, Inc. (NASDAQ:NOTV) Price Target To US$12.81

Dec 13

Headwaters Capital - Inotiv: Transformation Into A Critical Full-Service Contract Research Organization

May 25

Inotiv: Leading Mid-Market CRO Ups Its Game

Feb 07

We Think Inotiv (NASDAQ:NOTV) Has A Fair Chunk Of Debt

Dec 08

Calculating The Intrinsic Value Of Inotiv, Inc. (NASDAQ:NOTV)

Nov 17

Does Inotiv (NASDAQ:NOTV) Have A Healthy Balance Sheet?

Sep 02

Previsiones de crecimiento de beneficios e ingresos

NasdaqCM:NOTV - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
9/30/2026	626	N/A	57	N/A	1
9/30/2025	602	-28	47	N/A	3
9/30/2024	581	-30	37	N/A	3
12/31/2023	585	-33	4	29	N/A
9/30/2023	572	-105	0	28	N/A
6/30/2023	582	-340	-17	9	N/A
3/31/2023	597	-345	-42	-4	N/A
12/31/2022	586	-341	-50	-11	N/A
9/30/2022	548	-337	-42	-5	N/A
6/30/2022	427	-83	-38	-3	N/A
3/31/2022	277	-77	-15	10	N/A
12/31/2021	156	-72	-9	8	N/A
9/30/2021	90	11	-2	11	N/A
6/30/2021	75	0	-2	8	N/A
3/31/2021	68	-4	0	5	N/A
12/31/2020	65	-4	-4	1	N/A
9/30/2020	60	-5	-5	1	N/A
6/30/2020	59	-3	-6	2	N/A
3/31/2020	55	-2	-7	1	N/A
12/31/2019	48	-2	-6	2	N/A
9/30/2019	44	-1	-5	2	N/A
6/30/2019	38	-1	-2	3	N/A
3/31/2019	33	-1	0	4	N/A
12/31/2018	30	0	2	4	N/A
9/30/2018	26	0	2	3	N/A
6/30/2018	23	0	1	2	N/A
3/31/2018	23	1	1	2	N/A
12/31/2017	23	1	1	1	N/A
9/30/2017	24	1	N/A	1	N/A
6/30/2017	24	-1	N/A	2	N/A
3/31/2017	23	-2	N/A	1	N/A
12/31/2016	22	-3	N/A	2	N/A
9/30/2016	20	-3	N/A	1	N/A
6/30/2016	20	-2	N/A	1	N/A
3/31/2016	21	0	N/A	2	N/A
12/31/2015	22	0	N/A	2	N/A
9/30/2015	23	1	N/A	2	N/A
6/30/2015	24	1	N/A	2	N/A
3/31/2015	24	0	N/A	1	N/A
12/31/2014	24	0	N/A	0	N/A
9/30/2014	25	-1	N/A	2	N/A
6/30/2014	24	0	N/A	1	N/A
3/31/2014	23	0	N/A	2	N/A
12/31/2013	22	0	N/A	2	N/A
9/30/2013	22	1	N/A	2	N/A
6/30/2013	23	-2	N/A	2	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Se prevé que NOTV siga sin ser rentable en los próximos 3 años.

Beneficios vs. Mercado: Se prevé que NOTV siga sin ser rentable en los próximos 3 años.

Beneficios de alto crecimiento: Se prevé que NOTV siga sin ser rentable en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (3.6% al año) de NOTV crezcan más despacio que el mercado de US (8.1% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 3.6% al año) de NOTV crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de NOTV se prevé que sea elevada dentro de 3 años.

Descubre empresas en crecimiento

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Inotiv Crecimiento futuro

Future controles de criterios 0/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Consensus EPS estimates upgraded to US$1.15 loss

Price target increased by 22% to US$15.50

Inotiv, Inc. Reaffirms Earnings Guidance for the Fiscal 2024

Consensus EPS estimates fall by 18%

Earnings Release: Here's Why Analysts Cut Their Inotiv, Inc. (NASDAQ:NOTV) Price Target To US$12.81

Inotiv, Inc. Provides Earnings Guidance for the Fiscal Year 2024

Recent updates

Inotiv, Inc.'s (NASDAQ:NOTV) 57% Dip In Price Shows Sentiment Is Matching Revenues

New major risk - Share price stability

Inotiv (NASDAQ:NOTV) Takes On Some Risk With Its Use Of Debt

Consensus EPS estimates upgraded to US$1.15 loss

Inotiv, Inc.'s (NASDAQ:NOTV) Price Is Right But Growth Is Lacking After Shares Rocket 34%

Price target increased by 22% to US$15.50

An unknown buyer acquired RMS facilities in Spain and France from Inotiv, Inc. (NasdaqCM:NOTV).

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Inotiv, Inc. Reaffirms Earnings Guidance for the Fiscal 2024

Inotiv, Inc. to Report Q1, 2024 Results on Feb 07, 2024

Inotiv, Inc., Annual General Meeting, Mar 14, 2024

Consensus EPS estimates fall by 18%

Inotiv, Inc. (NASDAQ:NOTV) Stock Rockets 61% But Many Are Still Ignoring The Company

Chief Operating Officer recently bought US$150k worth of stock

Earnings Release: Here's Why Analysts Cut Their Inotiv, Inc. (NASDAQ:NOTV) Price Target To US$12.81

Full year 2023 earnings: EPS misses analyst expectations

Inotiv, Inc. Provides Earnings Guidance for the Fiscal Year 2024

Inotiv, Inc. to Report Q4, 2023 Results on Dec 11, 2023

Is Inotiv (NASDAQ:NOTV) A Risky Investment?

Inotiv, Inc. Announces Changes to Its Board Composition

Harlan Holdings Ltd. acquired Israeli Businesses from Inotiv, Inc. for $3.7 million.

Harlan Holdings Ltd. acquired Israeli Businesses from Inotiv, Inc. for $3.7 million.

New minor risk - Market cap size

Is Inotiv (NASDAQ:NOTV) A Risky Investment?

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Inotiv, Inc. Revises Earnings Guidance for the Full Year 2023

Inotiv, Inc. to Report Q3, 2023 Results on Aug 10, 2023

New minor risk - Share price stability

Price target decreased by 12% to US$15.06

Inotiv, Inc.(NasdaqCM:NOTV) dropped from Russell Small Cap Comp Value Index

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Inotiv, Inc. Confirms Revenue Guidance for the Fiscal Year 2023

Is Inotiv (NASDAQ:NOTV) Using Debt In A Risky Way?

Price target increased by 91% to US$17.17

Inotiv, Inc. Reiterates Financial Guidance for the Fiscal Year Ending September 30, 2023

Inotiv, Inc. Reports Goodwill Impairment Charges for the First Quarter Ended December 31, 2022

Inotiv, Inc. to Report Q1, 2023 Results on Feb 13, 2023

Inotiv, Inc., Annual General Meeting, Mar 16, 2023

Inotiv, Inc. Announces Board Changes

Inotiv, Inc. Provides Revenue Guidance for the First Quarter and Second Quarter to Fourth Quarter and Earnings Guidance for the Full Year Fiscal 2023

Inotiv, Inc. to Report Q4, 2022 Results on Jan 10, 2023

Inotiv, Inc. announced delayed annual 10-K filing

Inotiv, Inc. Provides Revenue Guidance for the Fiscal Year 2022

Inotiv, Inc. Announces Additional Site Consolidation Plan in the U.S

Inotiv, Inc. to Report Q4, 2022 Results on Dec 12, 2022

Price target decreased to US$50.33

Price target decreased to US$50.33

Bronstein, Gewirtz & Grossman, LLC Notifies Investors That A Class Action Lawsuit Has Been Filed Against Inotiv, Inc

Inotiv, Inc. Revises Earnings Guidance for the Fiscal Year Ending September 30, 2022

Law Offices of Howard G. Smith Files Lawsuit Against Inotiv, Inc

Inotiv, Inc. to Report Q3, 2022 Results on Aug 10, 2022

Inotiv, Inc. Decides to Close Two of its Facilities, a Purpose-Bred Canine Facility in Cumberland, Virginia

Inotiv adds 16% on settlement with U.S. over Virginia facility

Inotiv, Inc. (NasdaqCM:NOTV) acquired Protypia, Inc. for $11 million.

Inotiv completes acquisition of bioanalytical company Protypia for ~$11M

Inotiv, Inc. Announces Retirement of James Harkness as Chief Operating Officer, Effective from September 30, 2022

Kirby McInerney LLP Announces Filing of Securities Class Action on Behalf of Inotiv, Inc. Investors

Inotiv, Inc. Appoints Glenn Washer as Group President, Safety Assessment

Price target decreased to US$57.00

Headwaters Capital - Inotiv: Transformation Into A Critical Full-Service Contract Research Organization

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Inotiv, Inc. Provides Earnings Guidance for the Second Half and Full Fiscal Year 2022

Inotiv, Inc. (NasdaqCM:NOTV) acquired Histion, LLC on April 25, 2022.

Inotiv, Inc. announced delayed 10-Q filing

Price target increased to US$71.00

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Inotiv: Leading Mid-Market CRO Ups Its Game

Investor sentiment improved over the past week

Inotiv, Inc., Annual General Meeting, Mar 17, 2022